Vericel (VCEL) Non-Current Debt (2010 - 2018)
Vericel (VCEL) reported Non-Current Debt of $13.2 million for Q3 2018, up 78.15% on a YoY basis from $7.4 million in Q3 2017, and down 8.55% sequentially from $14.4 million in Q2 2018.
Vericel (VCEL) Non-Current Debt (2010 - 2018) Analysis & Trends
Vericel (VCEL) has 9 years of Non-Current Debt data on file, last reported at $13.2 million in Q3 2018.
- For the quarter ending Q3 2018, Non-Current Debt rose 78.15% year-over-year to $13.2 million; the trailing twelve-month figure through Sep 2018 stood at $13.2 million (up 78.15% YoY), and the FY2017 full-year result was $16.9 million, up 52675.0% from the prior year.
- Non-Current Debt slipped to $13.2 million in Q3 2018, from $14.4 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $16.9 million in Q4 2017 to a low of $32000.0 in Q4 2016.
- A 5-year average of $5.0 million and a median of $109000.0 in 2014 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt plunged 54.93% in 2016 and jumped 52675.0% in 2017, its largest moves.
- Tracing VCEL's Non-Current Debt over 5 years: stood at $109000.0 in 2014, then plunged by 34.86% to $71000.0 in 2015, then tumbled by 54.93% to $32000.0 in 2016, then jumped by 52675.0% to $16.9 million in 2017, then retreated by 21.94% to $13.2 million in 2018.
- Business Quant data shows VCEL's Non-Current Debt at $13.2 million in Q3 2018, $14.4 million in Q2 2018, and $15.6 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 13.18 Mn |
| Jun 30, 2018 | 14.42 Mn |
| Mar 31, 2018 | 15.65 Mn |
| Dec 31, 2017 | 16.89 Mn |
| Sep 30, 2017 | 7.40 Mn |
| Jun 30, 2017 | 8.04 Mn |
| Mar 31, 2017 | 8.68 Mn |
| Dec 31, 2016 | 32,000.00 |
| Sep 30, 2016 | 42,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | 71,000.00 |
| Sep 30, 2015 | 81,000.00 |
| Jun 30, 2015 | 91,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 109,000.00 |
| Sep 30, 2014 | 115,000.00 |
| Mar 31, 2013 | 2,000.00 |
| Dec 31, 2012 | 6,000.00 |
| Sep 30, 2012 | 9,000.00 |